Publication: Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology.
dc.contributor.author | Martínez-Laperche, Carolina | |
dc.contributor.author | Kwon, Mi | |
dc.contributor.author | Franco-Villegas, Ana C | |
dc.contributor.author | Chillón, M Carmen | |
dc.contributor.author | Castro, Nerea | |
dc.contributor.author | Anguita, Eduardo | |
dc.contributor.author | Dolz, Sandra | |
dc.contributor.author | Rodríguez-Medina, Carlos | |
dc.contributor.author | Hermosín, Lourdes | |
dc.contributor.author | Bellón, José M | |
dc.contributor.author | Prieto-Conde, Mª Isabel | |
dc.contributor.author | Barragán, Eva | |
dc.contributor.author | Gómez-Casares, Maite | |
dc.contributor.author | Ayala, Rosa | |
dc.contributor.author | Martínez-López, Joaquín | |
dc.contributor.author | González-Díaz, Marcos | |
dc.contributor.author | Díez-Martin, José Luis | |
dc.contributor.author | Buño, Ismael | |
dc.contributor.author | Cooperative Group for Molecular Biology in Haematology (GBMH) | |
dc.date.accessioned | 2023-01-25T09:44:39Z | |
dc.date.available | 2023-01-25T09:44:39Z | |
dc.date.issued | 2017-04-03 | |
dc.identifier.doi | 10.1111/bjh.14635 | |
dc.identifier.essn | 1365-2141 | |
dc.identifier.pmid | 28369773 | |
dc.identifier.uri | http://hdl.handle.net/10668/11043 | |
dc.issue.number | 4 | |
dc.journal.title | British journal of haematology | |
dc.journal.titleabbreviation | Br J Haematol | |
dc.language.iso | en | |
dc.organization | Área de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz | |
dc.organization | AGS - Jerez, Costa Noroeste y Sierra de Cáidz | |
dc.page.number | 542-546 | |
dc.pubmedtype | Letter | |
dc.pubmedtype | Multicenter Study | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.subject | Wilms Tumor 1 | |
dc.subject | acute myeloid leukaemia | |
dc.subject | chemotherapy | |
dc.subject | minimal residual disease | |
dc.subject | stem cell transplantation | |
dc.subject.mesh | Adolescent | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Female | |
dc.subject.mesh | Gene Expression Regulation, Leukemic | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Leukemia, Myeloid, Acute | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Neoplasm, Residual | |
dc.subject.mesh | Risk Assessment | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Spain | |
dc.subject.mesh | WT1 Proteins | |
dc.title | Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology. | |
dc.type | research article | |
dc.volume.number | 181 | |
dspace.entity.type | Publication |